Omeprazole and Regadenoson drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Omeprazole (omeprazole) and Regadenoson (regadenoson). Common drug interactions include depressed level of consciousness among females and chronic kidney disease among males.

The phase IV clinical study analyzes what interactions people have when they take Omeprazole and Regadenoson. It is created by eHealthMe based on reports of 16 people who take the same drugs from the FDA, and is updated regularly.

What is Omeprazole?

Omeprazole has active ingredients of omeprazole. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 410,631 Omeprazole users. Check the latest studies of Omeprazole.

What is Regadenoson?

Regadenoson has active ingredients of regadenoson. eHealthMe is studying from 357 Regadenoson users. Check the latest studies of Regadenoson.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 02, 2026

16 people who take Omeprazole and Regadenoson together, and have interactions are studied.

Omeprazole and Regadenoson drug interactions.

What are the common drug interactions of Omeprazole and Regadenoson, by gender? *:

female:

Depressed level of consciousness
Acute left ventricular failure (heart attack)
Acute respiratory failure
Cardiac failure
Cardiac failure congestive
Dizziness
Nausea (feeling of having an urge to vomit)

male:

Chronic kidney disease
Renal failure (kidney dysfunction)
Myoclonus (a brief, involuntary twitching of a muscle or a group of muscles)
Seizure (abnormal excessive or synchronous neuronal activity in the brain)
Anaemia (lack of blood)
Azotaemia (excess of urea or other nitrogenous compounds in the blood)
Bone density decreased
Fanconi syndrome acquired (self developed genetic disease of kidney damage due to defective transport system)
Fracture
Hyperphosphataemia (electrolyte disturbance in which there is an abnormally elevated level of phosphate in the blood)

What are the common drug interactions of Omeprazole and Regadenoson, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

Emotional distress
Hypokalaemia (low potassium)
Pain
Chronic kidney disease
Anaemia (lack of blood)
Azotaemia (excess of urea or other nitrogenous compounds in the blood)
Bone density decreased
Fanconi syndrome acquired (self developed genetic disease of kidney damage due to defective transport system)
Fracture
Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)

60+:

Depressed level of consciousness
Dyskinesia (abnormality or impairment of voluntary movement)
Unresponsive to stimuli
Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
Nephropathy (damage to or disease of a kidney)
Blood glucose decreased
Bradycardia (abnormally slow heart action)
Cardiac disorder
Chest pain
Dizziness

What are the existing conditions these people have? *

Hiv Infection: 5 people, 31.25%
Inflammation: 3 people, 18.75%
Asthma: 3 people, 18.75%
Hypersensitivity: 3 people, 18.75%
Pain: 3 people, 18.75%
High Blood Pressure: 3 people, 18.75%
Nausea (feeling of having an urge to vomit): 3 people, 18.75%
Fungal Infection: 3 people, 18.75%
Headache (pain in head): 2 people, 12.50%
Thrombosis (formation of a blood clot inside a blood vessel): 2 people, 12.50%

* Approximation only. Some reports may have incomplete information.

Do you take Omeprazole and Regadenoson?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously